carbon monoxide has been researched along with Left Ventricular Hypertrophy in 1 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritchie, RH | 1 |
| Irvine, JC | 1 |
| Rosenkranz, AC | 1 |
| Patel, R | 1 |
| Wendt, IR | 1 |
| Horowitz, JD | 1 |
| Kemp-Harper, BK | 1 |
1 review available for carbon monoxide and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond.
Topics: Carbon Monoxide; Cardiovascular System; Cyclic GMP; Guanylate Cyclase; Humans; Hypertrophy, Left Ven | 2009 |